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Preoperative normovolemic hemodilution was introduced for clinical 
application by Messmer and co-workers. Preoperative blood withdrawal 
of 1,500-2,000 ml by an isovolemic exchange with colloids or crystalloids 
(3 times the volume of blood withdrawn), in order to maintain a constant 
circulating volume, is offset by an adequate increase of cardiac output and 
an unchanged systemic oxygen transport capacity despite a decreased 
oxygen content. Patients lose fewer red cells and more plasma intraop- 
eratively. The retransfusion of autologous blood follows in the reverse 
order of collection after hemostasis is restored. The procedure is a safe 
and feasible method, which is not beset with the logistical problems of 
autologous blood predeposit and has the added advantage that fresh 
autologous blood is available at once for retransfusion. Provided that the 
contraindications are observed, the technique helps to reduce or even 
avoids the risks of homologous blood transfusion. The need for stored 
blood can be reduced by 20% to 90%, depending on the surgical 
procedure. 
The average blood loss in some elective surgical procedures 
ranges from 1,500 to 2,000 ml and, in most instances, 2-3 units 
of homologous blood are given intra- and postoperatively. For 
a long time blood was thought o be the ideal volume-replacing 
substance in cases of acute blood loss. Although the adminis- 
tration of blood is usually regarded as a safe procedure, 
intraoperative tranfusion is not without hazard. Potential com- 
plications include errors of typing, cross-matching, and admin- 
istration, as well as allergic reactions, alloimmunization to 
blood elements, and exposure to transmissible diseases includ- 
ing hepatitis, syphilis, malaria, cytomegalovirus, and acquired 
immunodeficiency s ndrome. Patients who are able to serve as 
their own blood donors, therefore, receive the safest of all 
possible transfusions--autologous blood. Increased safety 
alone would sufficiently justify autologous transfusion pro- 
grams. One alternative to avoid or reduce the administration of
homologous blood is autologous blood transfusion by means of 
acute preoperative hemodilution [1-7]. 
Arguments  for Hemodi lu t ion  
At the time of its clinical introduction in the early 1970's, the 
main reason for hemodilution during surgical procedures was to 
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save donor blood in order to reduce the risk of transmissible 
diseases, especially hepatitis. The incidence of posttransfusion 
hepatitis in West Germany is assumed to range from 0.02 to 
0.2% [8]. It must be stressed that hospital-acquired hepatitis is 
often a hospital infection rather than a transfusion-related 
disease [9, 10]. Nevertheless, the risk of transfusion-related 
hepatitis cannot be excluded. 
Increasing interest in avoiding homologous transfusion con- 
cerns immunologic aspects, i.e., alloimmunization of the pa- 
tients to constituents of transfused blood especially in young 
patients, which gives rise to problems with later blood transfu- 
sions [11-13]. 
Severe hemolytic reactions have been described and the 
lethality of such reactions is reported to be 1:30,000 [14]. Other 
arguments in favor of autologous transfusion are the biochem- 
ical changes that homologous blood undergoes during storage, 
i.e. loss of clotting factors, platelets, and 2,3-diphosphorglyce- 
rate. Homologous (banked) blood is known to cause a decrease 
of Ps0, resulting in a shift of the oxyhemoglobin dissociation 
curve to the left [15]. Ps0 is one of the important factors that 
influence the supply of oxygen to the tissues when there is a 
decrease in blood flow, as occurs in major vascular surgery. 
Intentional hemodilution does increase Ps0 and it is concluded 
that this procedure is beneficial to patients having major vas- 
cular surgery by increasing Ps0 of the blood and facilitating 
oxygen supply to the tissues [16]. 
Undoubtedly one main impetus for reexploring hemodilution 
has come from increasing evidence in the past few years that 
even a normal or high hemoglobin or hematocrit level repre- 
sents an important cardiovascular risk factor. This lends sup- 
port to what may at first seem an unlikely hypothesis, namely, 
that the normal range of hematocrit is not necessarily the 
optimal range. Hemodilution by no means treats the primary 
cause of ischemia, but it may compensate in some measure for 
narrowing of the vessels. Improved rheological properties of 
diluted blood under hemodilution allow better tissue perfusion. 
Lowering the blood viscosity by isovolemic hemodilution, 
therefore, has a wide range of clinical applications in obstruc- 
tive diseases of the veins and arteries and their surgical repair 
[17-22]. 
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Fig. 1. Changes in relative apparent viscosity (above) and plasma 
viscosity (below) from hemodilution i vivo. [] - values from low- 
molecular-weight gelatin, O = hydroxyethyl starch, 9 = high-molec- 
ular-weight gelatin, 9 = dextran 60 [21]. Reprinted with permission of 
publisher. 
Definition 
The term acute preoperative limited normovolemic hemodilu- 
tion is applied to a hematocrit reading of not less than 27%. 
Acute preoperative extreme hemodilution designates a hemato- 
crit level lower than 20%. 
Physiological Aspects of Hemodilution 
The normal hematocrit level of 45% provides optimal oxygen 
transport only at rapid flow rates. In all low-flow states it 
reduces 02 transport because of marked increases in blood 
viscosity. Acutely lowering hematocrit under isovolemic on- 
ditions not only favors recovery from such low-flow states, but 
at the same time improves the curtailed oxygen transport. The 
changes of whole blood viscosity must be regarded as the basic 
mechanism in controlling cardiac output (Fig. 1) [21]. Thus, 
maximum oxygen transport capacity coincides with the hema- 
tocrit ratio of 30%. It can be stated that limited hemodilution is
a procedure for the safe improvement of the flow properties of 
the blood without jeopardizing oxygen transport [21, 23-26]. 
The connection between viscosity, oxygen transport, and flow 
rates has supplied the basis for the concept of therapeutic 
hemodilution. 
Method of Preoperative Normovolemic Hemodilution 
The technique of acute preoperative hemodilution is as follows: 
Prior to or after induction of anesthesia immediately before 
surgery, depending on the patient's hematocrit reading which 
should be above 36% (> 12 g/100 ml Hb), 1,500-2,000 ml blood 
are withdrawn into standard collection bags and stored as CPD 
blood at room temperature. The amount of blood withdrawn is 
replaced by simultaneous i ovolemic infusion of colloids [hu- 
man albumin 5%, dextran 60-70, hydroxyethyl starch (HES) 
200 or 450] or with Ringer's lactate solution in a volume 3 times 
that of the blood withdrawn to maintain ormovolemia [2, 3]. In 
this way the circulating blood volume is kept constant, since the 
reduction of red cell mass is made up for by an increase in 
plasma volume. Under these conditions it is evident that, in 
comparison to a patient with a normal hematocrit ratio, a 
patient who has undergone hemodilution will lose fewer red 
blood cells (RBCs) with an identical operative blood loss 
because his blood loss mainly entails plasma. Blood loss during 
surgery is immediately replaced with colloids or crystalloids 
down to a hematocrit ratio of 27%, depending on the patient's 
condition. Reinfusion of the autologous blood should begin 
when hemostatis i restored. The units should be retransfused 
in the reverse order of collection without a filter, so as to ensure 
maximum retransfusion of the platelets in the autologous blood. 
Postoperative hematocrit values of 28-30% are tolerable under 
normovolemic conditions. 
The Compensatory Mechanisms of Preoperative Acute Limited 
Normovolemic Hemodilution 
The acute dilutional reduction of hematocrit demands the action 
of compensatory mechanisms. Oxygen content of arterial blood 
critically depends on cardiorespiratory function and the circu- 
latory blood volume. As long as normovolemia is provided, 3 
mechanisms are activated to maintain systemic oxygen trans- 
port despite the lowering of the arterial oxygen content of the 
blood: (a) increase in total and local blood flow rates, (b) 
increase in oxygen extraction, and (c) reduction of hemoglobin 
oxygen affinity by shifting the oxygen dissociation curve to the 
right. The first mechanism prevails for limited normovolemic 
hemodilution (hematocrit reading not lower than 27%). The 
most constant finding in patients in an awake state or under 
anesthesia s that the cardiac output rises when the hematocrit 
level is acutely reduced, if blood volume is maintained in the 
normal range [1, 2, 4-7, 21, 27, 28]. 
In a study of 25 patients undergoing abdominal surgery, 
hemodynamics were measured during acute limited normo- 
volemic hemodilution [5, 7]. Figure 2 shows the mean cardiac 
output percent (CO) of the 25 patients, using different solutions. 
During acute normovolemic hemodilution, the decrease in 
hematocrit and consequent decrease in Q-carrying capacity are 
offset by an increase in CO, which remains elevated throughout 
the operation period. Comparing the hemodynamic effects of 4 
different diluents, no statistically significant difference could be 
determined between the groups. It appears, however, that the 
use of dextran alone for hemodilution should be limited by the 
total amount of infused dextran because of its influence on 
coagulation (1.5 g/kg per 24 hours). 
As a result of the increase in cardiac output, the systemic 
oxygen transport capacity (product of cardiac output and arte- 
rial oxygen content) does not fall parallel to the dilutional fall in 
hematocrit. Based on theoretical considerations, Hint [18] 
predicted that systemic oxygen transport would result in a peak 
hematocrit ratio of approximately 30% (Fig. 3). Sunder-Plass- 
mann et al. were able to confirm that maximum oxygen trans- 
port did not coincide with the animals' control hematocrit ratio 
but with a ratio of about 30% [20, 26]. The increase in oxygen 
transport was explained by the enhancement of cardiac output 
being proportionally greater than the corresponding fall in 
arterial oxygen content of the blood. 
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Fig. 2A. Changes of cardiac output (CO, percent) when using dextran 
60 (solid line), dextran 60 and human albumin 5% (dotted line). B. 
Changes of cardiac output when using human albumin 5% (solid line), 
starch and human albumin 5% (dotted line). C = control values = 100%, 
after hemodilution 1, postoperatively 6 hr and 18 hr [5, 7]. Reprinted 
with permission of publisher. 
Figure 4 presents the calculated mean values of the systemic 
oxygen transport capacity for the above-mentioned study with 
different diluents [5]. The control values were set as 100% with 
a hematocrit reading in the range of 43% or 44%. A calculated 
oxygen transport capacity of 106% or 107% of the control 
values was found between hematocrit ratios of 29% and 33% 
with dextran 60, and dextran 60 or HES in combination with 
human albumin 5%. Plasma substitute (HA 5%) alone resulted 
in lower oxygen transport capacity values. The slightly 
hyperoncotic effect of dextran and HES explains the difference 
as compared to plasma. Laks et al. [4, 29], when using 
hemodilution on surgical patients, found a systemic oxygen 
transport of 110% at a hematocrit ratio of 27%. In contrast o 
Lundsgaard-Hansen who criticized the "fundamental curve" 
first published by Hint and Sunder-Plassmann, the results 
shown in Fig. 4 confirm the concept of hemodilution [30]. It 
must, however, be stressed that the concept of hemodilution is 
based on the fact that the oxygen transport rate and tissue 
oxygenation can be maintained in the control range despite 
considerable reductions in hematocrit, and the peak oxygen 
transport rate is never of major importance [6, 27, 31]. 
Indications and Contraindications for Hemodilution 
Preoperative hemodilution has been used routinely in many 
surgical fields, such as cardiac surgery [32-38], vascular surgery 
[16, 17, 19, 39-42], orthopedic surgery [4, 22, 28, 43-47], and 
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Fig. 3. Systemic oxygen transport capacity during normovolemic 
hemodilution with dextran 60 and normovolemic hemoconcentration 
with packed red cells in dogs. The dotted line represents the behavior of 
the curve predicted by Hint [18]. The solid circles represent values 
obtained uring isovolemic hemoconcentration by means of homolo- 
gous packed red cells. The open circles represent values obtained 
during isovolemic hemodilution by means of dextran 60 [26]. Reprinted 
with permission of publisher. 
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Fig. 4. Calculated systemic oxygen transport capacity after hemodilu- 
tion at different hematocrit ratios with 4 dilution solutions in 25 patients 
[5, 7]. Reprinted with permission of publisher. 
major general surgery [1, 2, 5, 7, 22, 43, 48-51]. Furthermore, it 
is especially indicated in patients with polycythemia since, in 
addition to providing autologous blood in these patients, 
hemodilution per se has beneficial effects [23, 52, 53]. 
Anemia, cardiac dysfunction, severe coronary artery disease, 
and severe hepatic disease are all relative contraindications to 
elective hemodilution. Furthermore, patients with pulmonary 
emphysema orobstructive lung disease are not good candidates 
for hemodilution because blood oxygenation could be endan- 
gered. 
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Coronary artery disease per se limits the potential and 
effectiveness of the compensatory mechanisms necessary to 
tolerate hemodilution. Gisselsson et al. demonstrated that, 
during hemodilution, the decrease in oxygen content in arterial 
blood after hemodilution was compensated by an increase of 
cardiac output (34%) and an increase of myocardial blood flow 
of 59% [46]. Thus, the myocardial blood flow increased propor- 
tionally more than the cardiac output, resulting in a virtually 
unchanged oxygen tension in coronary sinus blood in healthy 
patients. It could be shown that blood loss of up to 20% of the 
total volume can be replaced by dextran solutions without a 
significant decrease in the myocardial oxygen supply. Coronary 
artery disease otherwise leads to impaired perfusion of the 
myocardium, causing diffuse necrosis of the heart muscle with 
scar formation or myocardial infarction. This can diminish the 
pumping function of the left ventricle so that the ventricle is not 
able to increase cardiac output sufficiently during hemodilution. 
A significant stenosis of a coronary artery also limits the 
compensatory increase of coronary blood flow during hemodi- 
lution. In myocardial regions distal to a coronary artery stenosis 
where the oxygen supply is already borderlined at normal 
hemoglobin concentration, acutely reduced hemoglobin con- 
centration i  the presence of an unchanged coronary blood flow 
will cause a severe oxygen deficit and impairment of regional 
myocardial function [54]. 
According to K16vekorn et al. [36], the contraindications for 
hemodilution in patients undergoing coronary bypass surgery 
are: (a) Hb concentration < 140 g/L, (b) unstable angina, 
preinfarction syndrome, (c) abnormal left ventricular function, 
ejection fraction < 0.5, cardiac index < 2.5 1/m 2 per min, (d) left 
main coronary artery stenosis, (e) ischemic electrocardiogram 
changes at rest, and (f) impaired lung function. The recommen- 
dation to advocate preoperative hemodilution only for patients 
with coronary artery disease when they undergo coronary 
bypass surgery would help to avoid considerable problems due 
to hemodilution, which may complicate the intra- and postop- 
erative course. 
Avoidance of Homologous Transfusion by Hemodilution 
In the literature regarding hemodilution, a reduction in homol- 
ogous blood transfusion has been reported varying from 18% to 
90% [1, 2, 5, 7, 17, 32, 34--37, 39, 40, 42, 44, 47, 48, 50, 51, 55, 
56]. Preoperative hemodilution (in which blood is removed 
before surgery and is replaced with cell-free solutions) as well 
as intraoperative hemodilution (in which blood loss is replaced 
during surgery with cell-free solutions) are both unable to avoid 
homologous blood transfusion completely. In attempting to 
achieve this, extreme hemodilution, i.e., hemodilution below a 
hematocrit ratio of 20%, was performed [33, 35, 36, 38, 50, 51]. 
In order to decrease further the need for homologous blood, 
especially in children undergoing dorsal spinal fusion, a study 
was conducted to evaluate the saving effect of extreme 
hemodilution [57]. Table 1 presents data of 26 patients under- 
going Harrington's instrumentation. Fourteen patients were 
diluted to a hematocrit ratio of below 20% (EHD); 12 patients 
served as controls, receiving homologous blood transfusion 
corresponding to their intraoperative blood losses. The 2 groups 
were comparable in age, body-surface area, body weight, and 
anesthesia time. 
Table 1. Data of patients elected for study of extreme hemodilution 
(EHD) [57] ." 
Control group EHD group 
No. of patients 12 14 
Age (yr) 13.8 13.7 
Range 11-18 12-17 
Body surface area (m 2) 1.44 1.55 
Body weight (kg) 46 53 
Anesthesia (min) 309 316 
aNumbers in both control group and EHD group are mean figures. 
Reprinted with permission of publisher. 
Table 2. Transfusion therapy of patients elected for extreme hemodilu- 
tion (EHD) study [57]. 
Control group EHD group 
Homologous blood 
Intraoperative 4,120 (ml) 250 (ml) 
Postoperative 250 (ml) 500 (ml) 
Total 4,370 (ml) 750 (ml) 
Reprinted with permission of publisher. 
The need for homologous transfusion is shown in Table 2. 
The intraoperative demand for homologous transfusion aver- 
aged 4,120 ml in the control group in contrast o 250 ml in the 
EHD cohort. The total need for homologous blood at the time 
of discharge was nearly 6-fold higher in the control group. 
Acutely induced extreme hemodilution can be tolerated very 
well by these patients, thanks to an enormous capacity in these 
young people to offset the hemodilution by maintaining a 
constant circulating blood volume. Under special conditions 
with extensive and invasive monitoring, it is possible to cut 
down the use of excessive quantities of donor blood by extreme 
hemodilution and to diminish the severe clinical problems 
associated with massive homologous blood transfusions. Nev- 
ertheless, the procedure should only be performed in young 
healthy people. Furthermore, it inevitably requires monitoring 
of filling pressures of the heart as well as cardiac output. For 
this reason, extreme hemodilution is not suitable for routine 
use. Intraoperatively performed, extreme hemodilution was 
reported by Henling et al. in 110 children of the Jehovah's 
Witness faith who underwent operations for complete repair of 
congenital heart disease with cardiopulmonary bypass [35]. 
They did not receive any blood or blood products during 
hospitalization. The authors conclude that cardiac operations 
can be safely performed in children whose parents have denied 
them transfusion and suggest that hemodilution techniques 
might be used more extensively in children undergoing cardiac 
surgery. 
Combined Autologous Transfusion Programs with 
Hemodilution 
Only rarely can banked blood transfusion be avoided com- 
pletely; therefore, the combination of different autotransfusion 
techniques has been proposed [33, 35, 47]. Ninety-three pa- 
tients undergoing scoliosis surgery were studied in order to 
examine the efficiency of a combined autotransfusion program, 
namely, frozen blood products from preoperative donations, 
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Table 3. Transfusion therapy of patients elected for autologous trans- 
fusion programs [58]. 
No auto- Intraoperative 
transfusion autotransfusion 
Preoperative 
donation, intra- 
operative auto- 
transfusion, 
preoperative 
hemodilution 
No. of patients 17 39 
Intraoperative blood 
loss (L) 4.8 • 1.6 4.7 -+ 1.4 
Autologous trans- 
fusion (units) - 6.0 + 2.3 
Homologous trans- 
fusion (units) 8.4 -+ 2.4 3.9 • 2.1 
Patients without 
homologous 
transfusion 0/17 1/39 
37 
4.8 -+ 1.8 
3.1 -+0.8 
5.9 • 2.6 
1.4 • 1.6 
15/37 
Reprinted with permission of publisher. 
preoperative moderate hemodilution, and intraoperatively sal- 
vaged red cells after separation, washing, and concentration 
(Hemonetics Cell-Saver III) (Table 3) [58]. 
A profound reduction in homologous transfusion was 
achieved by the combination of autotransfusion techniques. In 
40% of group 3, the manifold risks of homologous transfusion 
was completely avoided at the time of discharge. Beside the 
saving of blood, the better quality of the autologous blood must 
be considered. The freezing of red blood cells and plasma 
greatly enhances the shelf life and the functional viability of 
preoperatively donated blood. In addition to the autologous 
blood products obtained, the patients gain the benefits of 
stimulated erythropoesis and a strong motivation resulting from 
involvement in their own medical care. 
Summary 
Preoperative and intraoperative h modilution is a part of a total 
approach to blood conservation and can be well tolerated to 
hematocrit ratios of 25% under a constant circulating normo- 
volemic volume. It helps to reduce homologous blood transfu- 
sion, improves nutritional capillary flow, and prevents throm- 
boembolic complications. For maximum effectiveness in 
avoiding homologous blood transfusion it should be combined 
with autologous blood predeposit, intraoperative scavenging, 
and postoperative autologous retransfusion. The key for ac- 
ceptance of hemodilution is appreciation of the fact that a 
hematocrit reading of 30% is adequate to prevent a tissue 
oxygen deficit in the operative patient. Acceptance of these 
principles may reduce demands for blood and protect patients 
from complications of homologous blood transfusion. 
R~sum6 
L'h6modilution normovol6mique pr6-op6ratoire a 6t6 instaur6e 
en chirurgie par Messmer et ses collaborateurs. Le pr616vement 
de sang du malade imm6diatement avant le d6but de l'acte 
chirurgical, ors de l'induction de l'anesth6sie, de 1,500 ~ 2,000 
ml de sang, et leur remplacement isovol6mique par des 
collo~des ou des cristalloMes (3 fois le volume de sang soustrait) 
dans le but de maintenir un volume circulatoire constant, est 
compens6 par une 616vation ad6quate du d6bit cardiaque t par 
une capacit6 inchang6e du transport de l'oxyg6ne en d6pit 
d'une diminution de sa saturation. De ce fait, les op6r6s perdent 
moins d'h6maties mais plus de plasma au cours de l'interven- 
tion. La retransfusion du sang autologue pr61ev6 est 6ffectu6e 
en ordre inverse des pr616vements anguins d6s que 
l'h6mostase st assur6e. La m6thode est praticable t sans 
danger. Elle n'est pas en but aux probl6mes logistiques pos6s 
par la transfusion de sang autologue pr61ev6 avant la date de 
l'intervention et conserv6. Elle a, pour avantage sup- 
pl6mentaire, le fait que le sang frais pr61ev6 au d6but de 
l'intervention est disponible d'embl6e pour la retransfusion. A 
condition que les contre-indications soient respect6es, cette 
technique aide ~t r6duire ou m6me ~ 6viter les risques inh6rents 
la transfusion du sang homologue. Les besoins en sang 
conserv6 peuvent ainsi 6tre r6duits de 20% h 90% en fonction de 
l'intervention chirurgicale pratiqu6e. 
Resumen 
La hemodilucidn normovol6mica preoperatoria fue introducida 
a la aplicaci6n clfnica pot Messmer y colaboradores. La 
remoci6n preoperatoria de 1,500-2,000 ml mediante un 
intercambio isovol6mico con coloides o con cristaloides (3 
veces el volumen extraido), para mantener un volumen 
circulatorio constante, es compensado por el adecuado 
aumento en el gasto cardiaco y una mantenida capacidad 
sist6mica de transporte de oxfgeno a pesar del disminuido 
contenido de oxfgeno. Los pacientes pierden menos globulos 
rojos y mayor cantidad de plasma intraoperatoriamente. La 
retransfusi6n de la sangre aut61oga se hace en el orden inverso 
al de su recolecci6n una vez que la hemostasis haya sido 
restablecida. E1 procedimiento representa un m6todo seguro y 
factible que no se acompafia de los problemas logfsticos del 
predepOsito de la sangre aut61oga y que posee la ventaja 
adicional que significa la disponibilidad inmediata de sangre 
aut61oga para retransfusi6n. Teniendo en cuenta la debida 
observaci6n a las  contraindicaciones, sta tecnica ayuda a 
reducir, y adn a eliminar, los riesgos de la transfusi6n sanguinea 
aut61oga. La necesidad de sangre almacenada puede ser 
reducida en 20% a 90%, segdn el procedimiento quirtirgico. 
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